The complex relationship between the animal host and the apathogenic, indigenous (autochthonous) microbiota residing in its gastrointestinal (GI) tract presents an intriguing immunological paradox. (Note that the suggestion of Lee [1] that "microbiota" is the taxonomically correct term to describe the complex intestinal microbial community is followed here.) Despite being exquisitely capable of distinguishing self from nonself, the host tolerates the residence of an antigenically and metabolically complex microbiota. The resident microbiota is advantaged by a rich and continuous supply of nutrients, as well as a favorable environment in which to live. In turn, the resident microbiota contributes to the nutritional economy of the host and plays a critical role in host resistance to enteric pathogens [2] [3] [4] [5] [6] [7] [8] . That such a mutualistic relationship exists implies that the protective and nutritional benefits of the intestinal microbiota are greater than the pathogenic threat offered by these foreign organisms. Indeed, all animals have, and seemingly require, a long-term cooperative association with indig-
The complex relationship between the animal host and the apathogenic, indigenous (autochthonous) microbiota residing in its gastrointestinal (GI) tract presents an intriguing immunological paradox. (Note that the suggestion of Lee [1] that "microbiota" is the taxonomically correct term to describe the complex intestinal microbial community is followed here.) Despite being exquisitely capable of distinguishing self from nonself, the host tolerates the residence of an antigenically and metabolically complex microbiota. The resident microbiota is advantaged by a rich and continuous supply of nutrients, as well as a favorable environment in which to live. In turn, the resident microbiota contributes to the nutritional economy of the host and plays a critical role in host resistance to enteric pathogens [2] [3] [4] [5] [6] [7] [8] . That such a mutualistic relationship exists implies that the protective and nutritional benefits of the intestinal microbiota are greater than the pathogenic threat offered by these foreign organisms. Indeed, all animals have, and seemingly require, a long-term cooperative association with indig-enous microbes in the GI tract. Studies with gnotobiotic (i.e., harboring a defined and specific microbiota comprised of у1 organism) animal models demonstrate most conclusively that indigenous microbes stimulate the normal maturation of host tissues and provide key defense and nutritional functions [9] [10] [11] [12] [13] [14] [15] . This mutualistic relationship has been selected over evolutionary time, resulting in a stable microbiota in mature individuals that is generally similar in composition and function among a diverse range of animal species [16] .
WHAT COMPRISES THE NORMAL MICROBIOTA?
Throughout the GI tract, the microbiota is characterized by its high population density, extensive diversity, and complexity of interactions. Bacteria are predominant, but Archaea and eukaryotic microbes are also represented. Bacterial populations as high as 10 10 -10 11 cfu per gram of contents belonging to as many as 400 different species have been found in the large intestine of mammals [1, [17] [18] [19] [20] . (Note that the extent to which the species concept applies to bacteria and Archaea is debated. The estimate of the intestinal microbiota harboring 400 species was derived originally from culture studies. However, this estimate is reasonably close when a cutoff of sharing у99% identity of the 16S ribosomal RNA [rRNA] gene sequence is used to denote a "species." See the work of Ley et al. [20] for further discussion.) In most cases, these numbers were derived from fecal samples and may not accurately represent the colonic microbiota, let alone the small-intestinal microbiota. The prominent role played by anaerobic bacteria in the large intestine is obvious from the fact that 199% of the bacteria isolated are unable to grow in the presence of oxygen [17] . Importantly, bacterial cells outnumber animal cells by a factor of 10 and have a profound influence on immunological, nutritional, physiological, and protective processes in the host [3, 17, 18, [20] [21] [22] [23] .
The extent of diversity of the microbiota is a fundamental question in intestinal microbial ecology. Cultivation-based techniques traditionally were used to study GI bacteria. However, cultivation-based approaches are limited by 3 major factors. First, one can culture only those organisms for which nutritional and growth requirements are known. Second, phenotypic criteria do not reliably enable phylogenetic identification. Third, cultivation techniques are, by design, tedious and impractical for studying ecosystems characterized by extensive microbial diversity. Recently, culture-based methods have been supplemented with molecular-ecology techniques that are based on the 16S rRNA gene [24] [25] [26] [27] . These techniques enable characterization and quantification of the microbiota while also providing a classification scheme to predict phylogenetic relationships. The choice of a particular molecular-based method is dependent on the particular question being asked. Clone libraries can be sequenced to identify the composition of the microbiota, often to the species level. Microbial community structure can also be analyzed via fingerprinting techniques, whereas dot-blot hybridization, fluorescent in situ hybridization (FISH), or quantitative PCR that target known taxa can measure the abundance of particular microbes. Emerging approaches, such as those based on functional genes and their expression and the combined use of stable isotopes and biomarkers, are also being developed and optimized to study metabolic activities of groups or individual organisms in situ.
Recent efforts to obtain a census of microbes based on 16S rRNA gene libraries demonstrate that the distal gut and fecal microbiota of healthy adult humans is dominated by 2 bacterial phyla, the Bacteroidetes and the Firmicutes, with Proteobacteria as the third most-prominent phyla and with Actinobacteria, Cyanobacteria, Fusobacteria, Spirochaeates, Vadin BE97, and Verrucomicrobia sequences also detected, although present at much lower densities [18, 19] . In contrast to the minimal phylogenetic diversity at the phyla level, the human gut microbiota is extremely diverse at the strain and subspecies level [18] . For example, it is estimated that the human distal gut harbors 17000 distinct phylotypes (distinguished according to the percent identity of 16S rRNA gene sequences being compared and the portion available of this sequence-generally, у97% identity for shorter sequences and у99% identity for full-length sequences), making it among the most diverse microbial ecosystems known [18] .
This type of ecological community structure (minimal divisions, each harboring multiple clusters of closely related phylotypes or "subspecies") raises numerous intriguing questions.
For example, what are the selection pressures that lead to the preservation of higher taxonomic clusters comprised of multiple closely related phylotypes? What is the extent of congruence between metabolic and phylogenetic diversity in these closely related taxonomic clusters? The issue, of course, relates in part to the problems of ascribing a certain value of 16S rRNA sequence similarity to the taxonomic definition of a species, or, in other words, the extent to which the species concept applies to the microbial world. These types of questions arose with the advent of molecular-based approaches for the study of complex microbial ecosystems and indeed are being debated by microbial ecologists and taxonomists [20, [28] [29] [30] . On the other hand, those interested in how the gut microbiota influences intestinal development and various diseases, both enteric and systemic, are more likely interested primarily in the metabolic activities of the microbiota, or its "metabolome," in current parlance.
To this end, another novel culture-independent method has emerged with significant potential for rapidly expanding the knowledge of the functional gene content of the human gut microbiota. Specifically, the cloning of large fragments of DNA isolated directly from an assemblage of microbes in a natural environment, such as the human gut, provides a method to access the "metagenome" of the community [31] . Single clones in these large insert libraries typically harbor complex loci that encode biosynthetic and metabolic pathways, because genes for most bacterial pathways are clustered in the genome, reducing the amount of work required to obtain full coverage of the complete metagenome. This approach is most useful for gaining information on the diversity and metabolic potential of uncultured organisms present in a particular environment, and, similar to most complex microbial ecosystems, the human gut microbiota is dominated by uncultured organisms. However, the gut microbiota of humans and animals has a long history of cultivation-based study, and, although particular phylotypes often do not belong to cultured isolates, many of the uncultured phylotypes do belong to taxa that harbor cultured representatives.
To date, observations from 2 metagenomic libraries of the human fecal microbiota have been published, as has a metagenomic analysis of the mouse cecum derived by random shotgun sequencing of bulk cecal DNA. The first published analysis of the metabolic and biosynthetic potential of the human fecal microbiome revealed enriched potential for the metabolism of glycans, amino acids, and xenobiotics and for the biosynthesis of vitamins and isoprenoids [32] . Manichanh et al. [33] compared the fecal microbiota of patients in remission for Crohn's disease with that of healthy donors by screening metagenomic libraries created from each group with 16S ribosomal DNA (rDNA) macroarrays, and they observed reduced phylotype diversity for the patients with Crohn's disease compared with the healthy control subjects. The metagenomic analysis of the mouse cecum focused on the very intriguing relationship between the gut microbiota and obesity and confirmed earlier findings that the microbiome of obese individuals has an increased capacity to harvest energy from the diet, relative to that of lean individuals [34] . Most recently, the composition of the fecal microbiota of obese human subjects was shown to exhibit taxonomic characteristics similar to that of genetically obese inbred mice [35] . These studies have significantly increased scientific and public interest in the role of the intestinal microbiota in human health in general. This, together with the availability of numerous molecular-based high-throughput methods for analyses of the complex gut microbiota, offers great promise for the identification of novel biomarkers of and therapeutic targets for both intestinal and systemic diseases.
WHERE ARE THE MICROBES?
The balanced diversity of the hindgut microbiota reflects, in part, the variety of nutrient substrates found in the environment. The diversity of bacterial populations within a particular ecosystem is directly related to the number of limiting nutrients, because each limiting nutrient will support the one bacterial species or strain that is most efficient in utilizing it. The stability of the hindgut microbiota, on the other hand, is likely a function of inhibition of bacterial multiplication by compounds such as short-chain fatty acids, hydrogen sulfide, deconjugated bile salts, and bacteriocins. It has been proposed that these bacterial metabolites may prolong the lag phase of allochthonous bacteria such that they are excreted from the local environment before they have a chance to colonize [36, 37] .
In addition to an increasing gradient of indigenous microbes from the stomach to the colon, characteristic radial distributions of organisms are found within each gut compartment. Specifically, at least 4 microhabitats have been described: the intestinal lumen, the unstirred mucus layer or gel that covers the epithelium of the entire tract, the deep mucus layer found in intestinal crypts, and the surface of intestinal epithelial cells [1, 38] . The bacterial groups that reside within these specific microhabitats have not been adequately described for any animal species, in part because of the technical challenges that define the task.
Knowledge of the mucus gel and particularly of bacterial populations that normally or abnormally colonize intestinal mucus is limited because fixation of intestinal tissues with conventional, dehydrating, cross-linking aldehyde fixatives results in detachment and loss of mucus. Matsuo et al. [39] demonstrated clearly that the use of an ethanol and acetic acid-based fixative enabled preservation of surface mucus in paraffin sections of human colonic samples. Two distinct layers were identified using conventional mucin histochemical stains, with the inner layer attached to the apical epithelial surface and continuous with intracrypt mucus. Colonic mucins did not mix homogeneously but rather formed a stacked or laminated structure of alternating sialomucins and sulfomucins. Bacteria were consistently observed within the laminated arrays of the outer layer, indicating the importance of the mucus gel in preventing the direct adherence of even mutualistic gut bacteria to colonic epithelial cells. A recent article on bacterial populations in ileal and colonic biopsy samples studied by FISH also demonstrated that bacteria are not attached to intestinal epithelial cells but are found predominantly attached to the luminal side of the intestinal mucus layer [40] . The photomicrographs presented in that article clearly show bacteria closely associated with the mucus layer, which seems to contradict the authors' conclusion that "intestinal commensal bacteria live in suspension in the lumen and that there is no specific mucus-adherent microflora" [40, p. 865] . When the biopsy sections were snap frozen, the mucus layer did appear to be preserved intact; however, the tissue sections used for FISH analysis were fixed with an aldehyde-based fixative, bringing into question the extent to which the fluorescently labeled 16S rRNA oligonucleotide probes penetrated the mucus layer. Although these technical challenges must be overcome before final conclusions can be reached regarding precisely where bacteria reside in the intestine, there are considerable published data and compelling growth considerations that support bacterial exploitation of the mucus niche, an issue with important implications for many human and animal intestinal disorders.
WHAT CONTROLS THE COMPOSITION OF THE MICROBIOTA?
Colonization of microbial populations in the mammalian GI tract begins during the birth process and involves complex successional changes from low diversity to high diversity until dense, stable populations colonize characteristic regions of the gut. The acquisition of a microbiota, which is remarkably similar among mammalian species, depends on both host and environmental factors [41] . The environmental factors include maternal genital microbiota, sanitary conditions, obstetric techniques, mode of delivery, geographical distribution of bacterial species, and mode of feeding [42] . Stepwise microbial succession seems to be critical for adequate development of gut physiology and immune functions that protect against allergies and inflammatory or autoimmune disorders later in life [6, 43, 44] .
Cultivation-based studies led to the common idea that strict anaerobes appear later in the bacterial succession, which is also supported, to a certain extent, by molecular-based studies [45] . The general concept is that aerobes and facultative anaerobes, which initially colonize the intestine, generate a reduced environment that is optimal for the growth of anaerobes. However, the presence of strict anaerobic genera at relatively early stages of microbiota development has also been observed in molecular-based studies. For example, recent molecular-based studies detected diverse bacteria as first colonizers, including Enterobacteriaceae, Bacteroides, Bifidobacterium, and Clostridium, with relatively large amounts of species variation among different individuals and different studies [45] [46] [47] [48] . Changes in food composition (weaning and introduction of solid food) have been considered to be the major factor, which drives shifts in microbial patterns after initial colonization [41, 42] . This possibility was addressed in several recent studies that examined successional patterns for the predominant bacterial population in infants over time by use of the 16S rDNA PCR-denaturing gradient gel electrophoresis (DGGE) community-profiling approach [47, [49] [50] [51] . All these studies showed simple bacterial profiles for the first few days of life, which became more complex with time. Some but not all of the major shifts in microbial patterns were related to differences in feeding practices [47, 51] . Favier et al. [47, 51] identified Escherichia coli and Clostridium species as initial colonizers, which were rapidly followed by various bacteria, including Bifidobacterium, Bacteroides, Clostridium, Streptococcus, Enterococcus, Ruminococcus, and Actinomyces. Songjinda et al. [49] showed that aerobes (mainly Pseudomonas) appeared on the day of birth and were quickly replaced by facultative anaerobes (Enterococcus, Streptococcus, and Enterobacteriaceae) during the first month of life, and strict anaerobes (Bifidobacterium) appeared by age 2 months. Schwiertz et al. [50] compared microbial succession patterns of hospitalized preterm infants with those of full-term infants for the first 4 weeks of life. E. coli, Enterococcus species, and Klebsiella pneumoniae were commonly found in the microbiota of preterm infants, and Bifidobacterium species were not detected. Most notably, the microbial profiles of these infants became more similar to one another over time, which is consistent with environmental factors influencing initial colonization and microbial succession patterns in early infancy.
Infants born by cesarean delivery experience different microbial succession patterns than do vaginally delivered infants, because of the lack of initial contact with the mother's vaginal microbiota. Cesarean-delivered infants tend to experience some delay in bacterial colonization, and their microbiota could be disturbed for up to 6 months [52] or 1 year [53] . One study showed that microbiota differences still exist at age 7 years, and significantly high numbers of clostridia were observed in vaginally delivered children [54] . The fecal microbiota of cesareandelivered infants also harbors significantly fewer Bacteroides species compared with that of vaginally delivered infants [52, 53] . Intriguingly, colonization with Bacteroides fragilis was more closely associated with maturation of humoral immunity in early infancy than was colonization with other bacterial groups [55] . Cesarean delivery is also associated with an increased risk of intestinal disorders or the development of allergic symptoms in later life [56] [57] [58] [59] .
The extent to which microbial succession patterns vary between breast-fed and formula-fed infants has been discussed extensively for some time, with differences in the pattern of Bifidobacterium colonization considered to be the most significant difference between the 2 modes of feeding. The general findings are a Bifidobacterium-dominant microbiota in breastfed infants and a more-diverse, adult-like microbiota in formula-fed infants [46, 60] . However, some recent publications do not demonstrate differences in bifidobacterial or general microbiota colonization between the 2 feeding-type groups [61, 62] . Given the clear influence of early exposure to the normal microbiota on the development of mucosal immunity and tolerance, additional research is needed to understand how interindividual differences and environmental factors such as diet affect microbial succession in the infant intestine.
Breast milk contains various bioactive factors, such as secretory IgA, lactoferrin, and a range of cytokines, and is considered to have a remarkable effect on the development of the neonatal mucosal immune system [63] . There is clear evidence, especially from studies with mice, that maternal secretory IgA supplied via milk sequesters commensal bacteria in the neonatal intestine, which delays active development of IgA production in neonates [64, 65] . It has been shown in mice that the decline in maternal IgA supply increases bacterial colonization in the pups' intestines, which leads to the accelerated secretion of selfsecretory IgA in the pups [66] . Bakker-Zierikzee et al. [67] observed no detectable fecal IgA in the first 10 days of life in formula-fed infants and observed that supplementation with pre-or probiotics in formula increased local secretory IgA production. A general lack of secretory IgA in formula-fed infants at an early age might partially explain the development of a more-diverse microbiota in these infants.
There is increasing evidence supporting a relationship between breast-feeding and the susceptibility of infants to atopic disorders. Specifically, low IgA concentrations in human milk are associated with the development of allergy in infants [68] [69] [70] . Siltanen et al. [71] demonstrated that long-term breastfeeding protects against atopy in children with atopic heredity, whereas it increases the risk of atopy in children without atopic heredity.
Microbial stimulation during infancy is particularly important for the development of the host intestine, especially the mucosal immune system [41, 55, 72] . For example, stimulation with intestinal bacteria at the neonatal stage and not at an older age was essential for full induction of oral tolerance in germ-free mice [72] . The hygiene hypothesis, first proposed by Strachan [73] , predicts that infections in early childhood might confer protection against the development of atopic diseases. Rautava et al. [74] recently suggested an extension of this hypothesis, in which they describe the importance of initial compositional development of microbiota as a key determinant of the development of allergic or autoimmune diseases. This view is consistent with studies demonstrating that the microbiota of allergic infants or children is different from that of their nonallergic counterparts [75, 76] . Differences in neonatal microbiota were observed before the development of allergic symptoms, which is also consistent with a compromised development of microbiota during infancy being a risk factor for allergic diseases in later life [76] .
Recent animal model studies and a limited number of human studies using molecular-based methods demonstrate that host genetic determinants likely shape the bacterial composition of the intestinal microbiota and that colonization is not simply a result of diet or chance exposure [25, 26, [77] [78] [79] . The mechanisms underlying this phenomenon are not understood; however, an emerging view is that host chemical features, which are genetically encoded (e.g., mucin chemotypes), are primary determinants of what comprises the normal microbiota, whereas dietary substrates principally influence metabolic activities of the microbes present, possibly shifting the prominence of certain populations. This updated view, enabled by molecular microbial ecology, has critical implications for diseases such as colorectal cancer, inflammatory bowel disease, and autoimmune disorders, in which the intestinal microbiota is a suspected contributor to pathogenesis. Sorting out the multifactorial interactions among host genetics and environmental influences engendered by mutualistic microbes as a reflection of diet in the context of health and disease states will undoubtedly be a difficult task.
The early work of Hoskins was among the first to indicate that one's genotype can influence the composition of the gut microbiota. This work demonstrated that the composition of blood-group antigen-specific glycosidases harbored by fecal bacteria reflected the specific blood type and, hence, the nature of mucin oligosaccharide side chains of the host [80] [81] [82] . The first molecular-based evidence that confirms an effect of genetic background on the human fecal microbiota was that published by Zoetendal et al. [77] , who demonstrated with a community fingerprinting approach (16S rDNA PCR-DGGE) that similarity between DGGE profiles of monozygotic twins was significantly greater than that between profiles of unrelated individuals. Similarity scores for fecal profiles from married couples sharing the same home (and, presumably, eating habits) were low and were not significantly different from scores for unrelated subjects. More recently, this finding was confirmed by others, with the additional observation that profiles of the fecal microbiota of monozygotic twins were significantly more similar than those of dizygotic twins [83] .
Similar observations have been reported for inbred mouse strains. In 2001, Vaahtovuo et al. [84] described strong associations for selected host genetic determinants and bacterial cellular fatty-acid profiles in fecal samples. This method does not identify specific bacteria; instead, it recognizes changes in predominant microbial populations and is also a less biased approach than is cultivation. Of particular interest was the observation that bacterial fatty-acid profiles were significantly different between inbred strains congenic for the major histocompatibility complex (MHC). In other words, the inbred strains that were compared shared the same genetic background and differed only at MHC loci, indicating that genes in this large genetic region somehow shape the composition of the intestinal microbiota, at least in mice. Together, these studies provide clear evidence that host genetics influences the composition of the intestinal microbiota, making the identification of the molecular basis of this phenomenon a necessity.
